A recent study showed that short-course radiation (40 Gy in 15 fractions) plus TMZ conferred a survival advantage over radiotherapy alone in elderly patients (65 years of age or older) with newly diagnosed GBM, especially in those with methylated MGMT status (70). The gene discussed is MGMT; the disease is glioblastoma.